An iconic Maine property is now available one mile from the boat launch on Kezar Lake. This family compound is the former location of Melder's German Restaurant and Brathaus, made famous by patron ...
Kezar Life Sciences has been handed a second clinical hold by the US Food and Drug Administration (FDA) in as many months. The FDA told the San-Francisco based biotech to halt the PALIZADE study ...
They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months. Image credit: Shutterstock / blentley Kezar Life Sciences has been handed a ...
Kezar Life Sciences has been hit by its second clinical hold from the FDA in as many months. The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...
SOUTH SAN FRANCISCO, Calif., November 12, 2024--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to ...
Topline data from PORTOLA Phase 2a clinical trial evaluating zetomipzomib in patients with autoimmune hepatitis (AIH) expected in first half 2025 Cash, cash equivalents and marketable securities ...
TD Cowen analyst Phil Nadeau maintained a Buy rating on Kezar Life Sciences (KZR – Research Report) yesterday. The company’s shares closed yesterday at $7.49. Nadeau covers the Healthcare ...